Literature DB >> 15701296

Comparison of the natural history of alcoholic and nonalcoholic fatty liver disease.

Shane J Mills1, Stephen A Harrison.   

Abstract

Fatty liver disease represents a common clinical entity. It is classically divided into alcoholic fatty liver disease (AFLD) and nonalcoholic fatty liver disease (NAFLD). Whereas AFLD occurs in as many as 10 million Americans, NAFLD represents the most common chronic liver disease and is the most common cause of liver enzyme abnormalities in the United States. Both diseases encompass the clinical spectrum of steatosis, steatohepatitis, and cirrhosis. Although they are histologically indistinct, AFLD and NAFLD follow different clinical courses. This article compares the natural history of these diseases.

Entities:  

Mesh:

Year:  2005        PMID: 15701296     DOI: 10.1007/s11894-005-0063-4

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  58 in total

1.  Liver fibrosis in overweight patients.

Authors:  V Ratziu; P Giral; F Charlotte; E Bruckert; V Thibault; I Theodorou; L Khalil; G Turpin; P Opolon; T Poynard
Journal:  Gastroenterology       Date:  2000-06       Impact factor: 22.682

2.  Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.

Authors:  J B Dixon; P S Bhathal; P E O'Brien
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

3.  Prevalence of and risk factors for hepatic steatosis in Northern Italy.

Authors:  S Bellentani; G Saccoccio; F Masutti; L S Crocè; G Brandi; F Sasso; G Cristanini; C Tiribelli
Journal:  Ann Intern Med       Date:  2000-01-18       Impact factor: 25.391

4.  Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

Authors:  P Angulo; J C Keach; K P Batts; K D Lindor
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

5.  Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study.

Authors:  A Poonawala; S P Nair; P J Thuluvath
Journal:  Hepatology       Date:  2000-10       Impact factor: 17.425

6.  Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.

Authors:  Jason M Hui; James G Kench; Shivakumar Chitturi; Archana Sud; Geoffrey C Farrell; Karen Byth; Pauline Hall; Mahbub Khan; Jacob George
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425

Review 7.  Advances in the understanding and treatment of nonalcoholic fatty liver disease.

Authors:  Stephen A Harrison; Adrian M Di Bisceglie
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 8.  Hepatocellular carcinoma with nonalcoholic steatohepatitis.

Authors:  Sayaka Mori; Takahiro Yamasaki; Isao Sakaida; Taro Takami; Eiki Sakaguchi; Teruaki Kimura; Fumie Kurokawa; Shiro Maeyama; Kiwamu Okita
Journal:  J Gastroenterol       Date:  2004       Impact factor: 7.527

9.  Nonalcoholic steatohepatitis: an expanded clinical entity.

Authors:  B R Bacon; M J Farahvash; C G Janney; B A Neuschwander-Tetri
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

10.  The natural history of nonalcoholic fatty liver: a follow-up study.

Authors:  M R Teli; O F James; A D Burt; M K Bennett; C P Day
Journal:  Hepatology       Date:  1995-12       Impact factor: 17.425

View more
  25 in total

1.  Hepatic fat quantification using the proton density fat fraction (PDFF): utility of free-drawn-PDFF with a large coverage area.

Authors:  Kun Young Kim; Ji Soo Song; Stephan Kannengiesser; Young Min Han
Journal:  Radiol Med       Date:  2015-05-08       Impact factor: 3.469

Review 2.  Extracellular vesicles as potential biomarkers for alcohol- and drug-induced liver injury and their therapeutic applications.

Authors:  Young-Eun Cho; Byoung-Joon Song; Mohammed Akbar; Moon-Chang Baek
Journal:  Pharmacol Ther       Date:  2018-04-03       Impact factor: 12.310

Review 3.  Alcohol-Associated Liver Disease: East Versus West.

Authors:  Phunchai Charatcharoenwitthaya; Suthat Liangpunsakul; Teerha Piratvisuth
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-01-13

4.  Alcoholic Liver Disease in Asia, Europe, and North America.

Authors:  Suthat Liangpunsakul; Paul Haber; Geoffrey W McCaughan
Journal:  Gastroenterology       Date:  2016-02-27       Impact factor: 22.682

5.  Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T.

Authors:  Takeshi Yokoo; Masoud Shiehmorteza; Gavin Hamilton; Tanya Wolfson; Michael E Schroeder; Michael S Middleton; Mark Bydder; Anthony C Gamst; Yuko Kono; Alexander Kuo; Heather M Patton; Santiago Horgan; Joel E Lavine; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  Radiology       Date:  2011-01-06       Impact factor: 11.105

Review 6.  Management of alcohol misuse in patients with liver diseases.

Authors:  Jennifer L Peng; Milan Prakash Patel; Breann McGee; Tiebing Liang; Kristina Chandler; Sucharat Tayarachakul; Sean O'Connor; Suthat Liangpunsakul
Journal:  J Investig Med       Date:  2016-12-09       Impact factor: 2.895

Review 7.  The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD).

Authors:  Qing Liu; Stig Bengmark; Shen Qu
Journal:  Lipids Health Dis       Date:  2010-04-28       Impact factor: 3.876

8.  Toll-like receptors in the pathogenesis of alcoholic liver disease.

Authors:  Jan Petrasek; Pranoti Mandrekar; Gyongyi Szabo
Journal:  Gastroenterol Res Pract       Date:  2010-08-17       Impact factor: 2.260

Review 9.  The role of fatty acids in the development and progression of nonalcoholic fatty liver disease.

Authors:  Christopher L Gentile; Michael J Pagliassotti
Journal:  J Nutr Biochem       Date:  2008-04-21       Impact factor: 6.048

Review 10.  Kupffer cells in the liver.

Authors:  Laura J Dixon; Mark Barnes; Hui Tang; Michele T Pritchard; Laura E Nagy
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.